StartupHistory

An open directory of startups through time

Public records · dated sources
Free to read. Free to reuse.

Company records / enterome.com

Enterome

Enterome (enterome.com): 8 changes recorded in its website history since November 2011. Homepage last checked 5 November 2026.

Recorded changes

Newest observations first. Each interval bounds when the website changed; it is not an exact event date.

  1. TractionBetween and

    Now claims “240 patients” on its homepage (was “200 patients”).

    Observed on the company’s website; business claims are not independently verified.

  2. TractionBetween and

    Now claims “200 patients” on its homepage (was “150 patients”).

    Observed on the company’s website; business claims are not independently verified.

  3. MessagingBetween and
    BeforeMicrobiome decoded ∙ Healthcare transformed
    AfterDelivering the promise of cancer immunotherapy

    Classifier interpretation of website text.

  4. HiringBetween and

    Added a careers page.

    Observed on the company’s website; business claims are not independently verified.

  5. HeadlineBetween and
    BeforeENTEROME IS HARNESSING THE MICROBIOME-IMMUNO-INFLAMMATION AXIS TO CREATE NEXT-GENERATION THERAPEUTICS
    AfterMicrobiome decoded ∙ Healthcare transformed

    Observed on the company’s website; business claims are not independently verified.

  6. HeadlineBetween and
    BeforeENTEROME’S MISSION: TO IMPROVE PATIENT HEALTH BY TRANSLATING THE MOLECULAR UNDERSTANDING OF THE ROLE OF THE HUMAN GUT MICROBIOME TO DELIV…
    AfterENTEROME IS HARNESSING THE MICROBIOME-IMMUNO-INFLAMMATION AXIS TO CREATE NEXT-GENERATION THERAPEUTICS

    Observed on the company’s website; business claims are not independently verified.

  7. FundingBetween and

    Announced on its homepage: “INVESTORS Enterome was established in 2012 and has raised close to €100 million in financing rounds with private equity funds (and strate…”.

    Observed on the company’s website; business claims are not independently verified.

  8. HeadlineBetween and
    BeforeACCESS PRESS ROOM
    AfterENTEROME TRANSLATE MOLECULAR UNDERSTANDING OF THE ROLE OF THE HUMAN GUT MICROBIOME TO DELIVER INNOVATIVE PERSONALIZED MEDICINE AND IMPROV…

    Observed on the company’s website; business claims are not independently verified.

First recorded website

Observed 15 November 2011

Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.

How it described itself

Enterome is Paris-based Bioscience Company co-founded by an experienced management team & world’s leading experts in human metagenomic field.

Enterome is Paris-based Bioscience Company co-founded by an experienced management team & world’s leading experts in human metagenomic field.

All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.

How it describes itself

Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.

  1. July 2023 – November 2026 · 7 captures · latest observed messagingDelivering the promise of cancer immunotherapy

    We are a clinical stage biopharmaceutical company developing novel drugs to transform human health based on our unique ability to de-code molecular interactions in the gut microbiome.

    This wording observed 5 November 2026.

    Inspect 7 captures in this group
    • 14 July 2023 · Delivering the promise of cancer immunotherapy archived page
    • 2 January 2025 · Delivering the promise of cancer immunotherapy archived page
    • 26 July 2025 · Delivering the promise of cancer immunotherapy archived page
    • 3 February 2026 · Delivering the promise of cancer immunotherapy archived page
    • 13 July 2026 · Delivering the promise of cancer immunotherapy archived page
    • 12 September 2026 · Delivering the promise of cancer immunotherapy archived page
    • 5 November 2026 · Delivering the promise of cancer immunotherapy current websiteHistorical capture not publicly available
  2. Seen January 2022 · 1 captureMicrobiome decoded ∙ Healthcare transformed

    We are a clinical stage biopharmaceutical company developing novel drugs to transform human health based on our unique ability to de-code molecular interactions in the gut microbiome.

    This wording observed 2 January 2022.

  3. Seen July 2020 · 1 captureENTEROME IS HARNESSING THE MICROBIOME-IMMUNO-INFLAMMATION AXIS TO CREATE NEXT-GENERATION THERAPEUTICS

    This wording observed 12 July 2020.

  4. July 2017 – January 2019 · 2 capturesENTEROME’S MISSION: TO IMPROVE PATIENT HEALTH BY TRANSLATING THE MOLECULAR UNDERSTANDING OF THE ROLE OF THE HUMAN GUT MICROBIOME TO DELIVER INNOVATIVE MEDICINES.

    This wording observed 10 January 2019.

    Inspect 2 captures in this group
    • 25 July 2017 · ENTEROME TRANSLATE MOLECULAR UNDERSTANDING OF THE ROLE OF THE HUMAN GUT MICROBIOME TO DELIVER INNOVATIVE PERSONALIZED MEDICINE AND IMPROVE PATIENT HEALTH. archived page
    • 10 January 2019 · ENTEROME’S MISSION: TO IMPROVE PATIENT HEALTH BY TRANSLATING THE MOLECULAR UNDERSTANDING OF THE ROLE OF THE HUMAN GUT MICROBIOME TO DELIVER INNOVATIVE MEDICINES. archived page
  5. Seen February 2016 · 1 captureACCESS PRESS ROOM

    This wording observed 1 February 2016.

  6. November 2011 – November 2014 · 2 capturesEnterome | Bioscience

    This wording observed 9 November 2014.

    Inspect 2 captures in this group
    • 15 November 2011 · Enterome is Paris-based Bioscience Company co-founded by an experienced management team & world’s leading experts in human metagenomic field. archived page
    • 9 November 2014 · Enterome | Bioscience archived page

Cite this record

StartupHistory, “Enterome” company record, https://startuphistory.org/c/enterome.com

Machine-readable: /c/enterome.com.json. How changes are found: method.